Manitoba Inflammatory Bowel Disease Cohort Study
NCT03262649 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 388
Last updated 2017-08-25
Summary
The Manitoba Inflammatory Bowel Disease (IBD) Cohort Study participants were drawn from a population-based research registry.
The cohort consisted of 388 adult enrollees with recent IBD onset who completed the baseline survey and interview in 2002 to 2003. Participants were followed every 6 months with surveys and annually with interviews. Diagnosis and disease type were verified by chart review.
Conditions
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
Sponsors & Collaborators
-
University of Manitoba
lead OTHER
Principal Investigators
-
Charles Bernstein, MD · University of Mantioba
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-03-01
- Primary Completion
- 2016-03-01
- Completion
- 2016-10-01
More Related Trials
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045 ·Status: UNKNOWN
-
Characterization of Phenotype and Genotype of Early Onset Enteropathies
NCT02614911 ·Status: RECRUITING
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
Long-term Functional Outcome of Children With Inflammatory Bowel Disease
NCT02152241 ·Status: COMPLETED
-
Significance of MAIT Cells in Inflammatory Bowel Disease
NCT05598346 ·Status: UNKNOWN
-
CorEvitas Inflammatory Bowel Disease (IBD) Registry
NCT03162549 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment
NCT05406934 ·Status: UNKNOWN
-
Immunological Profiles in Inflammatory Bowel Disease
NCT03366090 ·Status: UNKNOWN
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease
NCT02970149 ·Status: UNKNOWN
-
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506 ·Status: WITHDRAWN
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Genome Analysis Across Populations in Inflammatory Bowel Disease
NCT06042387 ·Status: RECRUITING
-
A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
NCT02493712 ·Status: COMPLETED ·Phase: PHASE2
-
Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases
NCT02508012 ·Status: COMPLETED ·Phase: NA
-
Prevention of Readmissions at IBD Centres of Excellence
NCT02931799 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain
NCT03689257 ·Status: COMPLETED
-
Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
NCT00573794 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
NCT02506179 ·Status: COMPLETED
-
Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease
NCT02693340 ·Status: UNKNOWN
-
Genetic Studies of Inflammatory Bowel Disease
NCT00340444 ·Status: COMPLETED
-
Does the Microbiome in IBD Change Alongside Special Treatment Scenarios?
NCT02526251 ·Status: COMPLETED
-
Genetic an Functional Studies of Patient With Inflammatory Bowel Disease
NCT03751722 ·Status: COMPLETED
-
Monroe County Inflammatory Bowel Disease (IBD) Registry
NCT01032525 ·Status: COMPLETED